Pharmaceuticals News and Research

RSS

Interdisciplinary approach leads to breakthroughs in bio nanotechnology research

Focusing on interdisciplinary research is now leading to breakthroughs in bio nanotechnology research. A new method for drug development has become a reality.

2 Apr 2011

Ther-Rx Corporation announces important initiative to reduce cost of Makena

As part of its ongoing efforts to ensure that high-risk women have access to FDA-approved Makena instead of unapproved, unregulated compounded drugs, Ther-Rx Corporation, a subsidiary of K-V Pharmaceutical Company, announced today important initiatives to reduce the cost of Makena (hydroxyprogesterone caproate injection) and encourage stakeholders to provide timely access to this important FDA-approved medication.

1 Apr 2011

ACADIA extends collaboration agreement with Allergan for drug discovery platform

ACADIA Pharmaceuticals Inc., a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that it has extended its drug discovery and development collaboration with Allergan, Inc.

1 Apr 2011

LifeSpan medicine launches new health and wellness program for kids

LifeSpan medicine is excited to announce the launch of the LifeSpan Healthy Kids Program. There is nothing more important to a lifespan of health than a good start. Who would not want to have a better, healthier childhood for their kids than they themselves had?

1 Apr 2011

Results of Boehringer Ingelheim's BI 201335 study presented at Annual Meeting of EASL

New data presented today at the 46th Annual Meeting of the European Association for the Study of the Liver demonstrate the antiviral activity of Boehringer Ingelheim's once-daily oral protease inhibitor, BI 201335, in both treatment-naive and -experienced patients with chronic genotype-1 hepatitis C virus, the most challenging genotype of HCV to treat.

1 Apr 2011

Rx Partnership receives Amerigroup grant to provide Virginians with medication access

The Amerigroup Foundation today announced that it has provided a grant of $10,000 to the Rx Partnership in Richmond, Virginia. The grant will be used to support increased access to medications in four free clinics in Virginia.

1 Apr 2011

Valeant, Promius sign deal to market Cloderm Cream

PromiusTM Pharma, LLC, an affiliate of Dr. Reddy's Laboratories, and Valeant Pharmaceuticals International, Inc. today jointly announced that they have signed a collaboration agreement for Cloderm Cream.

1 Apr 2011

Invida, Roche partner to commercialize primary care products

Invida Group Pte Ltd, the leading specialty pharmaceutical company focused on the commercialization of healthcare products throughout Asia Pacific, today announced that it has entered into a partnership agreement with Roche for the commercialization and marketing of that company's primary care portfolio throughout Korea.

1 Apr 2011

CPRIT awards $12.6M grant to Gulf Coast Consortia to develop new cancer treatments

The Gulf Coast Consortia has been awarded a grant of more than $12.6 million from the Cancer Prevention Research Institute of Texas to launch a collaborative program that brings together researchers with the common purpose of developing new cancer treatments.

1 Apr 2011

APEX-PD Phase III clinical study data to be presented at American Academy of Neurology Conference

Impax Pharmaceuticals, the branded products division of Impax Laboratories, Inc., today announced that IPX066 APEX-PD Phase III clinical study data will be presented in a Late Breaker Session at the 63rd annual meeting of the American Academy of Neurology Conference in Honolulu, Hawaii, held from April 9 to April 16.

1 Apr 2011

Pfizer reports details of financial interactions with the medical and scientific community

Pfizer Inc. today released a report detailing the company's financial interactions with health care professionals and researchers in 2010.

1 Apr 2011

Angiotech files Second Amended and Restated CCAA Plan of Compromise or Arrangement

Angiotech Pharmaceuticals, Inc. today announced that in connection with its previously announced creditor protection proceedings under the Companies' Creditors Arrangement Act (Canada), it and certain of its subsidiaries filed with the Supreme Court of British Columbia the Second Amended and Restated CCAA Plan of Compromise or Arrangement concerning, affecting and involving the Angiotech Entities.

1 Apr 2011

USPTO issues patent to Asterand's BioMAP technology

Asterand plc, a leading provider of human tissue-based services to pharmaceutical and biotechnology companies engaged in drug discovery research, and its subsidiary BioSeek LLC today announced that the United States Patent and Trademark Office has issued U.S. Patent Nos. 7,908,089 entitled "Patient classification" and 7,912,651 entitled "Function homology screening."

1 Apr 2011

Omeros announces outcome from OMS103HP Phase 3 study in patients undergoing ACL surgery

Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation, bleeding and disorders of the central nervous system, today reported the outcome from its Phase 3 program evaluating OMS103HP in patients undergoing arthroscopic anterior cruciate ligament reconstruction surgery.

1 Apr 2011

Tibotec presents TMC435 phase 2b study interim results against HCV at EASL meeting

Medivir AB, the emerging research-based specialty pharmaceutical company focused on infectious diseases, announces that their partner, Tibotec has presented the results of a planned Week 24 interim analysis of the phase 2b ASPIRE study for TMC435 in treatment experienced hepatitis C patients in a late-breaker session at the 46th Annual meeting of the European Association for the Study of the Liver, Berlin, Germany.

1 Apr 2011

CorMedix reports encouraging interim results from CRMD001 phase II study in Contrast Induced Acute Kidney Injury

CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiorenal disease, today announced its interim analysis and clinical update for CRMD001.

1 Apr 2011

IOVS journal publishes first global consensus report on MGD

The first global consensus report on meibomian gland dysfunction - a major cause of lid disease and evaporative dry eye - has been published in a special issue of the Investigative Ophthalmology & Visual Science journal.

1 Apr 2011

Glenmark initiates IND enabling studies of GBR 401 anti-CD19 monoclonal antibody in B cell lymphomas

Glenmark Pharmaceuticals announces the discovery and initiation of IND enabling studies of a Novel Biological Entity (NBE) lead candidate, GBR 401, an anti-CD19 monoclonal antibody. GBR 401 is developed completely in-house by Glenmark's Biologics Research Centre located in Switzerland.

1 Apr 2011

Vertex announces final results from Phase 3 REALIZE study against HCV

Vertex Pharmaceuticals Incorporated today announced final results from its pivotal Phase 3 REALIZE study that evaluated people with genotype 1 chronic hepatitis C whose prior treatment with pegylated-interferon and ribavirin was unsuccessful either because they relapsed, had a partial response or had a null response.

1 Apr 2011

Conatus CTS-1027 Phase 2 trial results against HCV presented at EASL meeting

Conatus Pharmaceuticals Inc. announced today 24-week interim results from a clinical trial with CTS-1027 in combination with Peginterferon Alpha-2a and ribavirin in a treatment experienced, hepatitis C virus null-responder patient population.

1 Apr 2011

Pharmaceuticals News and Research

Interdisciplinary approach leads to breakthroughs in bio nanotechnology research

Ther-Rx Corporation announces important initiative to reduce cost of Makena

ACADIA extends collaboration agreement with Allergan for drug discovery platform

LifeSpan medicine launches new health and wellness program for kids

Results of Boehringer Ingelheim's BI 201335 study presented at Annual Meeting of EASL

Rx Partnership receives Amerigroup grant to provide Virginians with medication access

Valeant, Promius sign deal to market Cloderm Cream

Invida, Roche partner to commercialize primary care products

CPRIT awards $12.6M grant to Gulf Coast Consortia to develop new cancer treatments

APEX-PD Phase III clinical study data to be presented at American Academy of Neurology Conference

Pfizer reports details of financial interactions with the medical and scientific community

Angiotech files Second Amended and Restated CCAA Plan of Compromise or Arrangement

USPTO issues patent to Asterand's BioMAP technology

Omeros announces outcome from OMS103HP Phase 3 study in patients undergoing ACL surgery

Tibotec presents TMC435 phase 2b study interim results against HCV at EASL meeting

CorMedix reports encouraging interim results from CRMD001 phase II study in Contrast Induced Acute Kidney Injury

IOVS journal publishes first global consensus report on MGD

Glenmark initiates IND enabling studies of GBR 401 anti-CD19 monoclonal antibody in B cell lymphomas

Vertex announces final results from Phase 3 REALIZE study against HCV

Conatus CTS-1027 Phase 2 trial results against HCV presented at EASL meeting

Event guide: World ADC Asia eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence